Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-5.03M.
ENTERPRISE VALUE (EV)
$-5.03M
Lisata Therapeutics, Inc.
Market Cap
$10.93M
Enterprise Value (EV)
$-5.03M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | $10.93M | $-5.03M |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.88M | $10.10M |
| Cerenome, Inc. (CNSY)vs › | $10.82M | $8.50M |
| BioVie Inc. (BIVI)vs › | $11.14M | $2.44M |
| Pluri Inc. (PLUR)vs › | $11.17M | $42.56M |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.21M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.64M | $2.23M |
| Lifeward Ltd. (LFWD)vs › | $10.60M | $12.22M |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | $4.56M |
| Satellos Bioscience Inc. (MSLE)vs › | $10.42M | $3.03M |
Market Cap
$10.93M
Total Debt
$0.00
Cash
$15.96M
Enterprise Value
$-5.03M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
